A A A Text Size
E-mail E-mail This Page
Home
Why Choose Fox Chase?
Patient Center
Learn About Cancer
 
Find a Doctor
Physicians Directory
Your Treatment Team
Patient Referral Resources
Molecular Medicine
Prevention, Risk and Screening
Research at Fox Chase
Partner Hospitals
For Health Professionals
Giving and Volunteering

Jeffrey M Farma, MD, FACS

Jeffrey M. Farma, MD

« More

Publications

Peer-Reviewed Publications:

  1. Santillan AA, Farma JM, Meredith KL, Shah NR, Kelley ST. Minimally Invasive Surgery for Esophageal Cancer. JNCCN. Submitted for publication.
  2. Farma JM, Pingpank JF, Libutti SK, Chang R, Wood BJ, Neeman Z, Kam A, Seidel G, Beresneva, T, Alexander HR. Percutaneous Hepatic Perfusion (PHP) with Melphalan for Patients With Metastatic Melanoma (MM) to the Liver. Mel Research. Accepted for publication.
  3. Farma JM, Santillan AA, Melis M, Walters J, Belinc D, Chen D, Eikman, E, Malafa M. PET/CT Fusion Scan Enhances CT Staging in Patients with Pancreatic Neoplasms. Ann Surg Oncol. Accepted for publication.
  4. Zager JS, Bui MM, Farma JM, Messina JL, Sondak VK. Proper Margins of Excision in Dermatofibrosarcoma Protuberans: Wide or Narrow? Ann Surg Oncol. May 2008.
  5. Farma JM, Puhlmann M, Cox D, Soriano, PA, Paciotti GF, Tamarkin L, Alexander HR. Direct Evidence for Rapid and Selective Induction of Tumor Neovascular Permeability by Tumor Necrosis Factor and a Novel Derivative, Colloidal Gold Bound Tumor Necrosis Factor. Int J Cancer. 120(11): 2474-80. June 2007.
  6. Farma JM, Mohiuddin, J, Grewal H. A pneumonia that will not go away. Contemporary Surgery. 63(4): April 2007.
  7. Farma JM, Hoffman JP. Non-neoplastic celiac axis occlusion in patients undergoing pancreaticoduodenectomy. Am J Surg. 193(3): 341-4. March 2007.
  8. Farma JM, Pingpank JF, Libutti SK, Bartlett DL, Ohl S, Beresneva T, Alexander HR Jr. Limited Survival in Patients with Carcinomatosis from Foregut Malignancies after Cytoreduction and Continuous Hyperthermic Peritoneal Perfusion. J Gastrointest Surg. 9(9): 1346-1353; December 2005.
  9. Puhlmann M, Weinreich DM, Farma JM, Carroll NM, Turner EM, Alexander HR Jr. Interleukin-1beta induced vascular permeability is dependent on induction of endothelial tissue factor (TF) activity. J Transl Med. 3:37; September 2005.
  10. Berger AC, Farma J, Scott WJ, Freedman G, Weiner L, Cheng JD, Wang H, Goldberg M. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol, 23(19): March 2005.
  11. Farma J, Nguyen D. Cardiac tamponade. Postgrad Med J. 81: 67; January 2005.
  12. Goldberg M, Farma J, Lampert C, Colarusso P, Coia L, Frucht H, Goosenberg E, Beard M, Weiner LM. Survival Following Intensive Preoperative Combined Modality Therapy with Paclitaxel, Cisplatin, 5-Fluorouracil and Radiation in Resectable Esophageal Carcinoma – A Phase I Report. J Thorac Cardiovasc Surg, 126(4): 1168-73; October 2003.
  13. Farma J, Leeser D, Furukawa S, Dempsey DT. Laparoscopic Repair of Diaphragmatic Hernia after Left Ventricular Assist Device. Journal of Laparoendoscopic & Advanced Surgical Techniques, Vol. 13(3): 185-9; June 2003

Book Chapters:

  1. Farma JM, Tada H, Daly JM. Surgical management of metastatic liver disease. Surgical Oncology, Multidisciplinary Approach to Difficult Problems. In publication.
  2. Santillan AA, Farma JM, Hagmaeir R, Cox CE, Riker AI. Hereditary Breast Cancer Syndromes. Inherited Cancer Syndromes-Current Clinical Management. In publication.
  3. Farma JM, Pingpank JF, Alexander HR. Isolated Hepatic Perfusion: Treating Unresectable Liver Metastases. Liver and Pancreatic Diseases Management (Advances in Experimental Medicine and Biology). Springer, New York, NY, April 2006.

Scientific Abstracts/Posters/Plenary Sessions:

  1. Farma JM, Melis M, Santillan AA, Walker J, Belinc D, Eikman EA, Malafa M. Positron Emission Tomography/ Computed Tomography Fusion Scans Enhances Preoperative Treatment Planning in Patients with Pancreatic Cancer. H. Lee Moffitt 2008 Fellows Education Research Symposium- Poster Presentation, Tampa, FL; May 2008.
  2. Helm J, Centeno BA, Melis M, Farma JM, Malafa M. Tumor Differentiation and Extrapancreatic Invasion are More Predictive of Survival than the TNM System in Resected Pancreatic Cancer. Society of Surgical Oncology 61st Annual Cancer Symposium- Poster Presentation, Chicago, IL; March 2008.
  3. Farma JM, Melis M, Santillan AA, Walker J, Belinc D, Eikman EA, Malafa M. Positron Emission Tomography/ Computed Tomography Fusion Scans Enhances Preoperative Treatment Planning in Patients with Pancreatic Cancer. Society of Surgical Oncology 61st Annual Cancer Symposium- Oral Presentation, Chicago, IL; March 2008.
  4. Farma JM, Hoffman JP. Non-Neoplastic Celiac Axis Occlusion in Patients Undergoing Pancreaticoduodenectomy(PD). Midwest Surgical Association Annual Meeting-Oral Presentation, Mackinac Island, MI; August 2006.
  5. Farma JM, Hoffman JP. Non-Neoplastic Celiac Axis Occlusion in Patients Undergoing Pancreaticoduodenectomy(PD). 2006 Philadelphia Academy of Surgery Annual Resident Paper Competition, Philadelphia, PA; February 2006.
  6. Farma JM, Cox D, Soriano PA, Paciotti GF, Myer L, Tamarkin L, and Alexander HR. Targeting Effects of Colloidal Gold Bound Tumor Necrosis Factor (TNF) to Tumor Neovasculature Permeability Using In Vivo Video Microscopy (IVVM). 96th American Association for Cancer Research Annual Meeting, Anaheim, CA; April 2005.
  7. Farma JM, Pingpank JF, Libutti SK, Chang R, Wood BJ, Neeman Z, Kam A, Seidel G, Beresneva, T, Alexander HR. Percutaneous Hepatic Perfusion (PHP) with Melphalan for Patients With Metastatic Melanoma (MM) to the Liver. Society of Surgical Oncology 58th Annual Cancer Symposium- Oral Presentation, Atlanta, GA; March 2005.
  8. Farma JM, Puhlmann M, Weinreich DM, Alexander HR. Direct Evidence for Rapid and Selective Induction of Tumor Neovascular Permeability by Tumor Necrosis Factor (TNF) Using In Vivo Videomicroscopy (IVVM). Society of Surgical Oncology 58th Annual Cancer Symposium, Atlanta, GA; March 2005.
  9. Farma JM, Pingpank JF, Libutti SK, Chang R, Wood BJ, Neeman Z, Kam A, Seidel G, Beresneva, T, Alexander HR. Percutaneous Hepatic Perfusion (PHP) with Melphalan for Patients With Metastatic Melanoma (MM) to the Liver. ASCO GI Symposium, January 2005.
  10. Berger AC, Farma J, Wang H, Scott W, Goldberg M. Complete Response to Neoadjuvant Chemoradiotherapy in Esophageal Carcinoma is Associated with Significantly Improved Survival. ASCO GI Symposium, January 2004.
  11. Goldberg M, Lampert C, Calorusso P, Coia L, Farma J, Frucht H, Goosenberg E, Beard M, Weiner LM. Survival following intensive preoperative combined modality therapy with paclitaxel, cisplatin, 5-flurouracil and radiation in respectable esophageal carcinoma: a phase 1 report. ASCO Annual Meeting, May 2002.

Invited Seminars and Grand Rounds:

  1. Multidisciplinary Fellow’s Conference Annual GI Symposium. H. Lee Moffitt Cancer Center, Tampa, FL. April 2008.
  2. Department of Surgery Grand Rounds, Temple University Hospital, Philadelphia, PA. Targeted Cancer Therapies: Are We There Yet?. May 2007.
  3. Surgery Branch, National Cancer Institute, Bethesda, MD. In-Vivo Video Microscopy. May 2005.

Video See Dr. Farma's video

Introductory Video of Dr. Farma

Surgical Oncology
Attending Surgeon

Meet other members of the
gastrointestinal cancer treatment team.
Meet other members of the
melanoma treatment team.
Meet other members of the
sarcoma treatment team.

Request an Appointment Online
New patients can request an appointment online or call 215-728-2570.

Appointments for Returning Patients

For general information, call:
1-888-FOX CHASE (1-888-369-2427).
An oncology certified nurse will assist you.

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111-2497

Clinical Expertise:

Colorectal cancer, gastric cancer, hepatobiliary cancer, sarcomas, melanomas, minimally invasive surgery.

Medical Education:

MD, Temple University School of Medicine, Philadelphia, PA, 2000

Residency:

Chief Resident, Temple University School of Medicine, Philadelphia, PA, 2005;
Resident, Temple University School of Medicine, Philadelphia, PA, 2003

Fellowships:

Surgical Oncology Fellow, H. Lee Moffitt Cancer and Research Institute, Tampa, Florida;
Surgical Oncology Fellow, Surgery Branch, National Cancer Institute, NIH, Bethesda, MD

Certification:

American Board of Surgery,
January 30, 2008

Professional Societies:

American College of Surgeons;
Society of Surgical Oncology;
Society for Surgery of the Alimentary Tract;
Philadelphia Academy of Surgery;
Florida Medical Association;
North American Neuroendocrine Tumor Society

Awards and Honors:

H. Lee Moffitt Cancer Center 2008 Fellow Education Research Symposium, Best Clinical Poster Presentation;
Temple University Surgery Resident Research Symposium Award, 2007;
H. Taylor Caswell Award, Department of Surgery Teaching Award for outstanding Chief Surgical Resident, 2007

Research Interests:

Outcomes studies in gastrointestinal and cutaneous malignancies. Regional therapies in the treatment of cancer.